What is the role of clofarabine in the treatment of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Clofarabine is a purine analogue that is approved by the FDA for the treatment of relapsed pediatric acute lymphocytic leukemia (ALL). A study of clofarabine and cytarabine in newly diagnosed patients with AML who were 50 years or older yielded a complete response rate of 52% and a CRi rate of 8%. Induction deaths occurred in 7% of patients. [76]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!